Literature DB >> 20625316

Contribution of D4-F to ABCA1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells.

Xie-Hong Liu1, Ji Xiao, Zhong-Cheng Mo, Kai Yin, Jin Jiang, Li-Bao Cui, Chun-Zhi Tan, Ya-Ling Tang, Duan-Fang Liao, Chao-Ke Tang.   

Abstract

Adenosine triphosphate-binding cassette transporter A1 (ABCA1) plays a crucial role in apolipoprotein A-I (apoA-I) binding activity and promotes cellular cholesterol efflux. ApoA-I mimetic peptide D4-F has reported to have the similar ability as apoA-I. However, the detailed mechanisms of ABCA1 regulation by D4-F are not understood. In the present study, we investigated the effects of D4-F on ABCA1 expression and ABCA1-dependent cholesterol efflux and examined the role of Cdc42/cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) pathway on the regulation of ABCA1 by D4-F in THP-1 macrophage-derived foam cells. Results showed that D4-F stabilized ABCA1 protein and enhanced ABCA1-dependent cholesterol efflux but had no effect on ABCA1 messenger RNA expression. We also revealed that D4-F enhanced cAMP level and PKA activity and ABCA1 serine phosphorylation. Short interfering RNA of PKA led to reduction of ABCA1 serine phosphorylation and ABCA1-mediated cholesterol efflux compensated by D4-F. PKA-specific activation by PKA agonist enhanced the upregulation of ABCA1 serine phosphorylation and ABCA1-mediated cholesterol efflux by D4-F. However, ABCA1 expression did not change by treatment with PKA agonist or PKA-short interfering RNA. We found that secramine B of Cdc42 inhibitor reduced the cAMP level compensated by D4-F. These results provide evidence that D4-F enhances ABCA1 serine phosphorylation and ABCA1-dependent cholesterol efflux through Cdc42/cAMP/PKA pathway in THP-1 macrophage-derived foam cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20625316     DOI: 10.1097/FJC.0b013e3181edaf69

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  12 in total

1.  High-density lipoprotein mimetic peptide 4F mitigates amyloid-β-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia.

Authors:  Dustin Chernick; Stephanie Ortiz-Valle; Angela Jeong; Suresh K Swaminathan; Karunya K Kandimalla; G William Rebeck; Ling Li
Journal:  J Neurochem       Date:  2018-11-26       Impact factor: 5.372

Review 2.  High-density lipoprotein: a novel target for antirestenosis therapy.

Authors:  Kai Yin; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2014-07-15       Impact factor: 4.689

Review 3.  A novel model of cholesterol efflux from lipid-loaded cells.

Authors:  Di-xian Luo; De-liang Cao; Yan Xiong; Xu-hong Peng; Duan-fang Liao
Journal:  Acta Pharmacol Sin       Date:  2010-09-13       Impact factor: 6.150

4.  Tristetraprolin-dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3.

Authors:  Kai Yin; Xiang Deng; Zhong-Cheng Mo; Guo-Jun Zhao; Jin Jiang; Li-Bao Cui; Chun-Zhi Tan; Ge-Bo Wen; Yuchang Fu; Chao-Ke Tang
Journal:  J Biol Chem       Date:  2011-02-21       Impact factor: 5.157

5.  Synthetic High-Density Lipoprotein (sHDL) Inhibits Steroid Production in HAC15 Adrenal Cells.

Authors:  Matthew J Taylor; Aalok R Sanjanwala; Emily E Morin; Elizabeth Rowland-Fisher; Kyle Anderson; Anna Schwendeman; William E Rainey
Journal:  Endocrinology       Date:  2016-06-02       Impact factor: 4.736

6.  Apolipoprotein A-I inhibits LPS-induced atherosclerosis in ApoE(-/-) mice possibly via activated STAT3-mediated upregulation of tristetraprolin.

Authors:  Kai Yin; Shi-lin Tang; Xiao-hua Yu; Guang-hui Tu; Rong-fang He; Jin-feng Li; Di Xie; Qing-jun Gui; Yu-chang Fu; Zhi-sheng Jiang; Jian Tu; Chao-ke Tang
Journal:  Acta Pharmacol Sin       Date:  2013-04-08       Impact factor: 6.150

7.  Control of hypercholesterolemia and atherosclerosis using the cholesterol recognition/interaction amino acid sequence of the translocator protein TSPO.

Authors:  Laurent Lecanu; Zhi-Xing Yao; Althea McCourty; El-Khansa Sidahmed; Maria E Orellana; Miguel N Burnier; Vassilios Papadopoulos
Journal:  Steroids       Date:  2012-11-23       Impact factor: 2.668

8.  Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.

Authors:  Anouar Hafiane; John K Bielicki; Jan O Johansson; Jacques Genest
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

9.  Possible Insulinotropic Action of Apolipoprotein A-I Through the ABCA1/Cdc42/cAMP/PKA Pathway in MIN6 Cells.

Authors:  Koki Matsumura; Naoki Tamasawa; Makoto Daimon
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-30       Impact factor: 5.555

10.  Ablation of Galectin-12 Inhibits Atherosclerosis through Enhancement of M2 Macrophage Polarization.

Authors:  En-Shyh Lin; Yu-An Hsu; Ching-Yao Chang; Hui-Ju Lin; Chih Sheng Chen; Lei Wan
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.